Financing life science: The ongoing saga
With the IPO market in decline, the venture capital market has emerged as the most important source of financing for life-science companies, notes Yer Biotech Blues columnist Michael Rosen. The good news is that the venture-capital market, while increasingly risk averse for early-stage businesses, has...